🧫
LysoPC treatment effects on lung fibroblast activation
active
experiment
Created: 2026-04-12T17:54:38
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-4077ba48-9736-4bbf-9f0e-2f2c60533391
🧫 Experiment Protocol
Exploratoryidiopathic pulmonary fibrosishuman lung fibroblastsproposed
Human lung fibroblasts were treated with identified lysophosphatidylcholines (LysoPCs) to investigate their biological effects on fibroblast activation and function. This experiment demonstrated that LysoPCs released by injured AECIIs could activate lung fibroblasts, thus promoting the progression of pulmonary fibrosis. The study examined fibroblast proliferation, migration, and fibrotic marker expression in response to LysoPC treatment.
PRIMARY OUTCOME
fibroblast activation markers
EXPECTED OUTCOMES
Increased fibroblast activation and pro-fibrotic responses
SUCCESS CRITERIA
Significant increase in fibroblast activation markers
PROTOCOL
Cell culture treatment with purified LysoPCs, assessment of activation markers
Source: PMID 38658970 ↗
🧫 Experiment Extras
PATHWAY
fibroblast activation, lipid signaling
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.